Prosecution Insights
Last updated: April 19, 2026

Nibec Co. Ltd.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
0
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18006387 PROTEIN COMPRISING ANTIBODY FOR TARGETING ONCOGENIC PROTEIN OR SINGLE CHAIN FRAGMENT VARIABLE THEREOF AND CANCER CELL PENETRATING PEPTIDE, AND USE OF THE SAME SULLIVAN, DENNIS JOHN 1642 Non-Final OA Jan 22, 2023

Managing Nibec Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month